Tuesday, February 25, 2025 | 04:56 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Molbio Diagnostics developing more tests for Truenat platform

Molbio is preparing test kits for zika, cholera, nipah, sickle cell anaemia, ch­olera, influenza, mumps, syp­hillis, yellow fever, HIV2 etc

Diagnostics
Premium

The firm has over 4,000 in­stallations in India, and aims to be a large global player in the molecular diagnostic seg­ment in the coming years. (Representative Image)

Sohini Das Mumbai
Molbio Diagnostics that inv­ented ‘Truenat Real-Time PCR’, the world’s only point-of-care (PoC) platform used by the WHO to detect tuberculosis, is now prepping up to co­me up with more tests on the same platform.
 
Apart from Covid-19 and tuberculosis, Molbio is preparing test kits for zika, cholera, nipah, sickle cell anaemia, ch­olera, influenza, mumps, syp­hillis, yellow fever, HIV2 etc.
 
Around 30 new tests are on the cards.
 
The Truenat platform gai­ned traction during the pandemic and in the last one year the firm sold close to 3,000 machines. This is 3X what it had sold in the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in